Imfinzi Approved in the US for Resectable Lung Cancer Treatment
The US has approved AstraZeneca's Imfinzi (durvalumab) combined with chemotherapy to treat…
Bristol Myers Squibb Expands Health Equity Grant Initiatives to Improve Health Outcomes
PRINCETON- March 2024- Bristol Myers Squibb unveiled a $1.8 million initiative to…